GM crops—lessons from medicine

See allHide authors and affiliations

Science  16 Sep 2016:
Vol. 353, Issue 6305, pp. 1187
DOI: 10.1126/science.aaj1764

You are currently viewing the summary.

View Full Text


Earlier this year, the U.S. National Academy of Sciences released a report on genetically engineered crops that is comprehensive but offers few recommendations in terms of regulatory guidance. Although it acknowledges that a process-based regulatory system is becoming less technically feasible, the report suggests that regulators focus on safety aspects of technology when considering approval. We believe that products of new technologies should be regulated not only on the basis of their benefit-risk profiles, but also on their societal context and need.